SBIR-STTR Award

Discrimination test for early galucoma detection
Award last edited on: 3/13/12

Sponsored Program
SBIR
Awarding Agency
NIH : NEI
Total Award Amount
$350,000
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Jerome Leight

Company Information

LKC Technologies Inc

2 Professional Drive Suite 222
Gaithersburg, MD 20879
   (301) 840-1992
   info@lkc.com
   www.lkc.com
Location: Single
Congr. District: 06
County: Montgomery

Phase I

Contract Number: 1R43EY005136-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1983
Phase I Amount
$50,000
The objective of this project is to develop and evaluate a new instrument designed to psychophysically detect the earliest signs of loss of vision due to nerve damage from glaucoma or ocular hypertension. The proposed instrument is a computer-controlled projection perimeter that employs pattern discriminations, as opposed to conventional measures of luminance contrast thresholds, as the criterion for detecting visual field abnormalities. This project consists of developing the hardware and software for a prototype model of the Pattern Discrimination Perimeter. This model will be subjected to testing at LKC to verify that it is ready for clinical evaluation. Clinical testing will begin at completion of Phase I.National Eye Institute

Phase II

Contract Number: 2R44EY005136-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
1985
(last award dollars: 1986)
Phase II Amount
$300,000

The objective of this project is to develop and evaluate a new instrument designed to psychophysically detect the earliest signs of loss of vision due to nerve damage from glaucoma or ocular hypertension. The proposed instrument is a computer-controlled projection perimeter that employs pattern discriminations, as opposed to conventional measures of luminance contrast thresholds, as the criterion for detecting visual field abnormalities. This project consists of developing the hardware and software for a prototype model of the Pattern Discrimination Perimeter. This model will be subjected to testing at LKC to verify that it is ready for clinical evaluation. Clinical testing will begin at completion of Phase I.National Eye Institute